Industry News - Tag: GlaxoSmithKline
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
1 May 2020
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 46% at constant exchange rates in the first quarter of 2020, following consolidation of Pfizer’s Consumer Healthcare products and the COVID-19 pandemic.
20 March 2020
The US Consumer Healthcare Products Association (CHPA) has created the new position of vice president for scientific affairs and dietary supplements, Europe’s Committee for Herbal Medicinal Products (HMPC) has elected a new chair, and GlaxoSmithKline (GSK) has a new non-executive director.
19 February 2020
The US Food and Drug Administration (FDA) has switched GlaxoSmithKline’s (GSK’s) topical pain reliever Voltaren (diclofenac sodium topical gel 1%) from prescription-to-OTC status. GSK said the OTC version, called Voltaren Arthritis Pain, would be “available on US shelves in spring 2020”.
9 January 2020
Strides Pharma Science has a new chief, The Carlyle Group has taken on Ian Read, and GlaxoSmithKline has a new member of its Corporate Executive Team.